Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...

Johnson & Johnson (JNJ) is joining Eli Lilly (LLY) in attempting to court favor with President Donald Trump by announcing ...

Priti Patel, MP for Witham, has raised concerns over the impact of the Labour Government’s budget on family-run businesses.

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

Here are four perfect high-yield dividend stock picks for investors looking to follow the lead of the top money managers on ...

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Meta Platforms, Inc.

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

A group of more than 100 Democratic lawmakers sent a letter to President Donald Trump on Friday warning about the potential ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...